COVID-19 Outbreak-Global Fibrinogen Concentrates Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
- 110 Pages
- Region: Global
Fibrinogen, also known as coagulation factor I, is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen deficiency is a rare bleeding disorder characterized by mild to severe form of bleeding. The three types for fibrinogen deficiencies are: afibrinogenemia, hypofibrogenemia, and dysfibrinogenemia. In severely bleeding patients, fibrinogen concentrate significantly improves whole blood clot firmness and reduces the postoperative transfusion requirements. Currently, fibrinogen concentrates are widely used instead of traditional sources of fibrinogen, such as fresh frozen plasma and cryoprecipitate.
The Fibrinogen Concentrates market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Fibrinogen Concentrates industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Fibrinogen Concentrates market can be split based on product types, major applications, and important countries as follows:
Key players in the global Fibrinogen Concentrates market covered in Chapter 12:
Jiangxi Boya Bio-Pharmaceutical
ProFibrix BV (Medicines Company)
Harbin Pacific Biopharmaceutical
Shanghai XinXing Medical
Johnson & Johnson (Ethicon)
Hualan Biological Engineering
In Chapter 4 and 14.1, on the basis of types, the Fibrinogen Concentrates market from 2015 to 2025 is primarily split into:
Human Fibrinogen Concentrates
Animal Fibrinogen Concentrates
In Chapter 5 and 14.2, on the basis of applications, the Fibrinogen Concentrates market from 2015 to 2025 covers:
Congenital Fibrinogen Deficiency
Surgical Procedures (Trauma Patients, Cardiovascular Surgery Patients, PPH Patients, Plastic Surgery Patients)
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
Europe (Covered in Chapter 8 and 14)
Asia-Pacific (Covered in Chapter 9 and 14)
Middle East and Africa (Covered in Chapter 10 and 14)
South America (Covered in Chapter 11 and 14)
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025